Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3041184	u-inh-o	— (—)	49	124	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Tuberculosis

44.30

18.23

2.7

1.6

—

Abnormal findings on diagnostic imaging of lung

9.00

9.37

2.1

2.7

—

ILD medications: immunosuppressive drugs

8.55

8.15

2.5

2.4

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

6.89

7.91

2.1

2.7

—

Certain infectious and parasitic diseases

9.01

7.64

2.6

2.7

—

ILD medications

4.90

7.39

2.5

2.4

—

COPD differential diagnosis

8.91

6.82

2.3

3.0

—

ILD differential diagnosis

8.91

6.81

2.3

3.0

—

Excluding asthma or asthma-COPD overlap

8.91

6.81

2.2

3.0

—

ILD medications: prednisolone, methylprednisolone, prednisone

4.55

6.27

2.4

—

First line medication for Crohn's disease

4.26

6.09

2.5

—

GASTRO-related operations

8.78

5.99

2.4

2.9

—

Any gastric operation

8.78

5.99

2.4

2.9

—

Other pulmonary diagnosis

7.79

5.65

2.4

3.0

—

L04AX Other immunosuppressants

5.60

5.35

2.6

2.8

—

Second line medication for Crohn's disease

5.38

5.20

2.6

2.8

—

Diseases of the respiratory system

7.24

5.08

1.8

3.3

—

Certain infectious and parasitic diseases, including avohilmo

7.51

4.82

2.0

2.9

—

Pneumonias (Asthma/COPD co-morbidities)

3.73

4.74

2.7

2.5

—

Autoimmune diseases excluding thyroid diseases

3.68

4.64

2.8

2.2

—

Persons with potential health hazards related to communicable diseases

5.74

4.40

2.8

2.1

—

Influenza and pneumonia

3.40

4.14

2.7

2.4

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

3.51

3.97

2.8

2.7

—

3.51

3.97

2.8

2.7

—

Examination and observation for other reasons

5.64

3.90

3.3

2.1

—

Neurological diseases

3.70

3.75

2.5

2.7

—

Polyarthropathies

3.91

3.73

2.6

2.8

—

All pneumoniae

3.25

3.71

2.8

2.4

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

3.22

3.69

2.8

2.4

—

Asthma, unspecified (mode)

7.21

3.60

2.9

2.4

—

Asthma, unspecified (mode), excluding more controls

7.15

3.58

2.9

2.4

—

Pleural effusion

7.78

3.55

1.7

1.9

—

Oral corticosteroids

3.14

3.43

2.7

2.3

—

Used for control exclusion in common control thyroid runs

3.15

3.28

2.3

—

Asthma (only as main-diagnosis)

5.59

3.25

3.3

3.0

—

Autoimmune diseases excluding thyroid diseases, strict definition

3.17

2.9

2.3

—

Autoimmune diseases

3.04

3.13

2.3

2.2

—

Bacterial pneumonia (organism specified)

4.12

3.11

2.7

2.0

—

Disorders of lens

4.01

3.09

1.8

2.9

—

Disorders of other endocrine glands

4.43

3.06

2.0

2.7

—

Pneumonia, organism unspecified

3.07

3.03

2.5

2.4

—

Asthma

5.16

3.03

2.9

3.0

—

Gout, FINNGEN

4.97

3.03

3.3

2.5

—

Asthma, excluding more controls

5.13

3.02

2.9

3.0

—

Rheumatoid arthritis

5.06

3.01

2.0

3.1

—

Complications of surgical and medical care, not elsewhere classified

2.92

2.99

2.5

—

Inflammatory bowel disease treatment related agents

2.87

2.95

2.9

2.3

—

Gout

4.90

2.93

3.3

3.1

—

Abnormalities of breathing

3.10

2.91

3.1

2.6

—

Contact with and exposure to communicable diseases

4.69

2.90

2.1

2.2

—

Gout, unspecified

5.39

2.86

3.6

2.4

—

Rheumatoid arthritis, including avohilmo

4.45

2.79

2.0

2.6

—

Gout, idiopatic and unspecified

5.00

2.72

3.6

2.3

—

Fever of other and unknown origin

3.90

2.70

2.2

2.1

—

Asthma (only as main-diagnosis), excluding more controls

4.91

2.70

3.1

3.0

—

Asthma-related pneumonia

4.20

2.66

2.9

2.5

—

Asthma, hospital admissions 3, pneumonia

4.20

2.66

2.9

2.5

—

Asthma-related pneumonia or sepsis

4.20

2.66

2.9

2.5

—

General symptoms and signs

2.96

2.61

3.3

2.3

—

Other special examinations and investigations of persons without complaint or reported diagnosis

4.14

2.58

2.9

2.1

—

Asthma (mode)

4.67

2.58

3.1

3.0

—

Other bacterial diseases

2.78

2.57

2.1

2.8

—

Any reimbursement code in KELA

4.10

2.55

2.9

2.3

—

Sulfasalazine

5.46

2.54

2.0

2.4

—

Other bacterial diseases, including avohilmo

2.65

2.51

2.1

2.6

—

Asthma (diagnoses ohter than nonallergic)

2.77

2.49

2.8

2.3

—

Other anaemias

3.51

2.49

3.0

2.8

—

Reimbursement for rheumatic diseases

3.44

2.46

1.9

2.8

—

Aplastic and other anaemias

3.43

2.43

3.0

2.8

—

Propionic acid derivatives

5.03

2.40

1.9

2.9

—

Anti-inflammatory and antirheumatic products, non-steroids

5.03

2.40

1.9

2.9

—

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

5.00

2.40

1.7

2.7

—

Visual disturbances and blindness

3.33

2.38

2.8

2.4

—

Gastrointestinal diseases

3.76

2.38

1.6

1.7

—

ILD, hospital admissions 1, main diag only

6.25

2.37

2.6

1.5

—

Papulosquamous disorders

3.64

2.36

3.3

2.5

—

Bacterial pneumonia, not elsewhere classified

3.70

2.35

3.0

2.1

—

Bacterial pneumoniae

3.70

2.35

3.0

2.1

—

Symptoms and signs involving the circulatory and respiratory systems

2.71

2.29

1.8

2.6

—

Senile cataract

3.42

2.27

1.8

3.1

—

Autoimmune diseases related-to ILD

2.78

2.25

3.1

2.3

—

Parasetamol

2.93

2.20

2.6

2.8

—

General examination and investigation of persons without complaint and reported diagnosis

3.78

2.19

3.0

2.1

—

Pure hypercholesterolaemia

2.79

2.17

3.0

2.4

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

4.29

2.15

1.7

2.3

—

Other/unspecified seropositive rheumatoid arthritis

4.29

2.15

1.7

2.3

—

Seropositive rheumatoid arthritis, wide

4.29

2.15

1.7

2.3

—

Persons encountering health services for examination and investigation

3.65

2.11

2.8

2.1

—

Asthma-related infections

2.92

2.08

2.7

2.3

—

Asthma, hospital admission 2, infections

2.92

2.08

2.7

2.3

—

Other congenital malformations, including avohilmo

5.00

2.07

1.6

—

Spondylopathies

2.71

2.04

1.8

2.9

—

Other and unspecified anaemias

3.13

2.03

3.1

2.8

—

Seropositive rheumatoid arthritis

3.98

2.02

1.7

3.2

—

Special screening examination for infectious and parasitic diseases

5.21

2.01

2.8

1.9

—

Visual disturbances

3.08

2.01

2.8

2.3

—

Other external causes of accidental injury

2.75

2.00

2.4

2.6

—

ILD, hospital admissions

4.55

1.94

2.6

1.9

—

Interstitial lung disease

4.55

1.94

2.6

1.9

—

Interstitial lung disease endpoints

4.55

1.94

2.6

1.9

—

Other diseases of pleura

3.02

1.94

1.8

2.7

—

External causes of morbidity and mortality

3.01

1.93

1.9

3.0

—

Psoriasis

3.75

1.93

3.7

2.3

—

Retinal detachments and breaks

3.75

1.93

2.2

2.5

—

Tramadol

2.75

1.92

2.2

2.7

—

Disorders of lipoprotein metabolism and other lipidaemias

2.57

1.89

3.3

2.3

—

Other disorders of ear

2.42

1.88

2.3

2.5

—

Diseases of oesophagus, stomach and duodenum

2.32

1.84

2.9

2.5

—

Other cataract

3.71

1.84

2.2

3.3

—

Other interstitial pulmonary diseases

4.17

1.82

2.6

2.0

—

Other (seronegative) rheumatoid arthritis, wide

4.17

1.82

1.8

2.6

—

Concussion

3.19

1.82

2.3

2.8

—

Gastro-oesophageal reflux disease

2.62

1.80

2.9

2.4

—

Bacterial infection, other or unspecified

2.81

1.79

2.5

2.6

—

Substance abuse, excluding more controls

2.78

1.77

2.3

2.7

—

Diseases of the skin and subcutaneous tissue

2.33

1.77

2.6

2.1

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

2.31

1.74

2.4

2.5

—

COPD/asthma related infections

2.40

1.73

2.8

2.7

—

COPD/asthma/ILD related infections

2.40

1.73

2.8

2.7

—

Oxycodone

2.99

1.73

1.6

2.6

—

Medical observation and evaluation for suspected diseases and conditions

3.25

1.73

2.4

2.1

—

Bacterial infection, other or unspecified, including avohilmo

2.73

1.73

2.5

2.6

—

Solid cancers

2.66

1.71

1.6

2.7

—

Other respiratory diseases principally affecting the interstitium

3.85

1.71

2.6

2.0

—

All influenza

3.85

1.71

2.0

1.9

—

Cough

3.29

1.71

1.7

2.8

—

Other medical care

2.68

1.70

3.0

2.3

—

Depression

2.37

1.68

2.3

2.6

—

Unspecified mental disorder

3.16

1.66

1.7

2.5

—

Dyspnoea

2.33

1.66

2.4

—

Chronic sinusitis

3.15

1.66

2.5

2.7

—

Falls/tendency to fall

2.24

1.65

2.2

2.7

—

Chronic lower respiratory diseases

2.21

1.62

3.1

2.2

—

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

3.57

1.61

1.4

2.1

—

Asthma, hospital admissions , main diagnosis only

2.35

1.59

3.2

2.2

—

Exposure to unspecified factor

2.20

1.59

2.1

2.7

—

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

2.51

1.59

1.9

2.4

—

Malaise and fatigue

2.75

1.57

4.0

2.1

—

Injury, poisoning and certain other consequences of external causes

2.92

1.56

1.9

2.8

—

Intracranial trauma

2.78

1.55

2.3

2.8

—

Coxibs

3.75

1.51

2.2

2.9

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

3.29

1.50

2.8

1.5

—

Acetic acid derivatives and related substances

3.69

1.49

1.8

2.9

—

2.12

1.48

2.5

—

Endocrine, nutritional and metabolic diseases

2.40

1.46

2.6

2.3

—

Diseases of oral cavity, salivary glands and jaws

2.44

1.45

1.6

2.2

—

Fall on same level involving ice and snow

2.50

1.45

2.1

2.7

—

Diseases of pulp and periapical tissues and dental caries

2.43

1.44

1.6

2.7

—

Use of hypnotics and sedatives

2.14

1.44

2.8

2.7

—

Mycoses

3.13

1.44

3.2

2.2

—

Diseases of arteries, arterioles and capillaries

2.36

1.43

2.2

2.6

—

Disorders of choroid and retina

2.33

1.42

2.4

—

Iron deficiency anaemia

2.67

1.40

2.7

2.5

—

Malignant neoplasm

2.29

1.38

1.7

3.0

—

Malignant neoplasm

2.29

1.38

1.7

3.0

—

Benign neoplasms

2.11

1.37

1.9

2.6

—

Solid cancers, including Hilmo

2.28

1.37

1.7

3.0

—

Psychiatric diseases

2.20

1.36

1.9

2.9

—

Cervical disc disorders

2.94

1.36

2.4

2.5

—

Other diseases of anus and rectum

2.93

1.35

2.8

—

Diseases of the eye and adnexa

2.25

1.34

2.4

—

Accidents

2.25

1.34

2.3

2.6

—

Other chronic obstructive pulmonary disease

2.58

1.32

3.2

2.0

—

Any event in cancer register

2.19

1.31

1.7

3.0

—

Malignant neoplasm, wide definition

2.18

1.31

1.7

2.9

—

COPD

2.56

1.31

3.2

2.0

—

Diseases of pulp and periapical tissues, including avohilmo

2.07

1.31

2.0

2.7

—

Diseases of the ear and mastoid process

2.07

1.30

2.4

2.6

—

Substance abuse

2.40

1.30

2.3

2.5

—

Covid-19 confirmed case

2.50

1.30

3.0

2.5

—

Disorders of eyelid, lacrimal system and orbit

2.15

1.29

2.4

2.6

—

Renal tubulo-interstitial diseases

2.15

1.29

1.8

2.6

—

Mental and behavioural disorders due to psychoactive substance use

2.36

1.29

2.3

2.5

—

Asthma/COPD (KELA code 203)

2.15

1.27

2.6

2.2

—

Any death

2.33

1.27

3.0

2.5

—

Kela-code for severe mental illness

2.63

1.21

1.8

2.5

—

Other viral diseases

2.62

1.21

3.0

1.8

—

Later onset COPD

2.68

1.20

3.6

2.2

—

Anxiety (asthma-related co-morbidities)

2.40

1.20

2.0

2.7

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

2.10

1.20

2.1

2.5

—

Persons encountering health services in circumstances related to reproduction

0.00

1.19

0.0

2.6

—

Neoplasms

2.21

1.19

1.6

2.8

—

Low back pain

2.16

1.19

2.6

3.0

—

Fracture of rib(s), sternum and thoracic spine

2.50

1.15

1.6

2.4

—

Diseases of liver

2.50

1.15

3.4

2.3

—

Diaphragmatic hernia

2.50

1.15

1.4

2.8

—

Glaucoma suspect

2.50

1.15

2.6

2.7

—

Other neurological diseases

2.07

1.14

2.1

2.6

—

Metabolic disorders

2.07

1.14

3.4

2.5

—

Persons encountering health services in other circumstances

2.47

1.13

2.8

2.2

—

Other septicaemia

2.48

1.13

2.4

2.6

—

Chronic apical periodontitis

1.92

1.13

2.4

2.5

—

Transient ischemic attack

2.32

1.12

2.0

2.7

—

Complications of procedures, not elsewhere classified

2.01

1.11

2.9

2.5

—

Renal failure

2.29

1.11

1.7

2.7

—

Complications of medical and surgical care

2.00

1.11

2.9

2.5

—

Provisional assignment of new diseases of uncertain etiology

2.24

1.09

2.7

2.5

—

Codes for special purposes

2.24

1.09

2.7

2.5

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.21

1.08

2.7

2.6

—

Malignant neoplasm, including Hilmo

2.10

1.08

1.7

3.0

—

Diseases of middle ear and mastoid

2.20

1.08

2.7

2.4

—

Mood [affective] disorders

2.00

1.07

2.4

2.7

—

Inflammatory diseases of female pelvic organs

2.44

1.07

1.6

2.9

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

2.38

1.07

3.6

2.1

—

Sensorineural hearing loss

2.07

1.07

2.0

2.5

—

Mood disorders

2.00

1.07

2.4

2.7

—

Other septicaemia, including avohilmo

2.35

1.06

2.4

2.6

—

Mood disorders, excluding more controls

2.03

1.06

2.6

2.8

—

Genitourinary diseases

2.19

1.05

2.6

2.9

—

All kidney diseases

1.97

1.05

1.8

2.6

—

Conductive and sensorineural hearing loss

1.99

1.04

2.0

2.5

—

Other diseases of lip and oral mucosa

2.27

1.03

4.2

2.3

—

Other diseases of the digestive system

2.27

1.03

1.4

2.3

—

Septicaemia

2.28

1.02

2.4

2.6

—

2.25

1.02

2.2

2.5

—

Other viral diseases, including avohilmo

2.25

1.02

3.0

2.0

—

Intracranial injury

2.04

1.01

2.7

2.5

—

Malignant neoplasm of digestive organs, including Hilmo

2.30

1.01

2.0

2.9

—

Opioids

1.99

1.01

2.5

2.6

—

Erysipelas, including avohilmo

1.99

0.98

2.6

2.8

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

1.84

0.97

2.1

2.5

—

Finngen Rheumatological endpoints

1.82

0.96

1.7

2.8

—

Peripheral artery disease

2.26

0.94

1.8

2.8

—

Cardiovascular diseases

2.27

0.94

2.0

2.2

—

Atherosclerosis, excluding cerebral and coronary sclerosis

2.24

0.94

1.8

2.8

—

COPD related to multimorbidity

2.20

0.93

3.2

2.4

—

Nutritional anaemias

2.20

0.93

2.7

2.6

—

COPD, hospital admissions

2.20

0.92

3.2

2.4

—

Congenital malformations, deformations and chromosomal abnormalities

2.19

0.92

2.2

2.5

—

Tonsillectomy and adenotomy

2.20

0.92

1.5

2.5

—

Coxarthrosis

2.15

0.91

1.8

2.9

—

COPD, early/later onset

2.10

0.90

3.2

2.3

—

Spinal stenosis

2.10

0.90

2.5

2.6

—

Implicit Sepsis

1.90

0.88

2.1

2.8

—

Dorsopathies

1.87

0.88

2.3

2.8

—

Presence of other functional implants

2.05

0.87

2.0

3.1

—

All anxiety disorders

2.02

0.87

2.0

2.5

—

Benzodiazepine use

1.82

0.87

2.3

2.5

—

Dental caries, including avohilmo

1.86

0.86

2.6

2.5

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.99

0.86

2.5

2.7

—

Ischemic heart diseases

1.83

0.85

2.6

2.5

—

Any mental disorder

1.85

0.85

2.0

2.8

—

Other chronic obstructive pulmonary disease, including avohilmo

1.97

0.85

3.2

2.4

—

Exposure to other specified factors

1.81

0.85

2.4

2.6

—

Diseases of male genital organs

2.01

0.84

2.7

2.3

—

Coxarthrosis [arthrosis of hip](FG)

1.97

0.84

1.8

3.0

—

Implicit Sepsis, including avohilmo

1.78

0.84

2.1

2.7

—

Symptoms and signs involving the digestive system and abdomen

1.78

0.84

2.8

2.2

—

Implicit bacterial Sepsis, including avohilmo

1.92

0.83

1.7

2.7

—

Caries of dentine, including avohilmo

1.78

0.82

2.6

2.5

—

Other retinal disorders

1.90

0.82

2.7

2.5

—

Glaucoma

1.89

0.81

2.7

2.6

—

Bronchitis

1.74

0.81

2.3

2.6

—

Condition for Implicit Sepsis (Organ dysfunction codes)

1.73

0.81

2.1

2.7

—

Symptoms and signs involving the urinary system

1.72

0.81

2.1

2.5

—

Necrosis of pulp, including avohilmo

1.85

0.80

2.5

2.6

—

Sleep disorders (combined)

1.74

0.80

1.6

2.7

—

Bleeding

1.70

0.79

2.1

2.5

—

Other diseases of upper respiratory tract

1.74

0.79

2.5

2.6

—

Bacterial Sepsis

1.84

0.79

2.2

2.7

—

Extrapyramidal and movement disorders

0.00

0.79

0.0

2.5

—

Dentofacial anomalies [including malocclusion]

1.80

0.77

2.3

2.5

—

Carpal tunnel syndrome

1.79

0.77

2.2

2.6

—

Other dorsopathies, not elsewhere classified

1.73

0.77

2.6

2.8

—

Hypothyroidism, other/unspecified

1.74

0.77

2.1

2.6

—

COPD, hospital admission 2, with asthma infections

2.15

0.76

3.6

2.5

—

Headache

2.14

0.75

1.2

2.1

—

Anxiety disorders, excluding more controls

1.86

0.74

2.9

2.8

—

Transport accidents

2.08

0.74

2.0

2.6

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

2.06

0.74

2.4

2.5

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

1.62

0.73

2.4

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1.62

0.73

2.3

2.6

—

Dental operations

1.80

0.72

1.9

—

Alcohol use disorder, ICD-based

2.00

0.72

2.4

2.0

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

1.98

0.72

2.4

2.0

—

Selective serotonin reuptake inhibitors

1.61

0.72

3.4

2.4

—

Other soft tissue disorders, not elsewhere classified

1.60

0.71

1.7

2.7

—

COPD, hospital admissions 1, only main diagnosis

1.95

0.71

2.0

2.8

—

Spondylosis

1.95

0.71

2.4

2.7

—

Diverticular disease of intestine

1.74

0.71

1.7

2.6

—

Open wound of wrist and hand

1.93

0.71

2.4

2.2

—

Obesity due to excess calories

1.92

0.70

2.0

2.6

—

Other disorders of skin and subcutaneous tissue

1.69

0.69

1.9

2.7

—

Heart failure, not strict

1.68

0.68

3.0

2.6

—

Lower back pain or/and sciatica

1.68

0.68

2.7

2.6

—

Other arthrosis

1.86

0.68

2.0

2.9

—

Percutaneous Coronary Intervention

1.64

0.66

2.7

2.5

—

Coronary revascularization (ANGIO or CABG)

1.63

0.66

2.7

2.5

—

Injuries to the thorax

1.78

0.66

1.6

2.5

—

Implicit bacterial Sepsis

1.79

0.66

1.8

2.8

—

Mental and behavioural disorders due to alcohol

1.76

0.65

2.4

2.6

—

Explicit Sepsis

1.75

0.64

2.4

2.6

—

Acute sinusitis

1.75

0.64

3.8

2.5

—

Explicit Sepsis, including avohilmo

1.74

0.64

2.4

2.6

—

Persons encountering health services in other circumstances, wide

1.61

0.64

3.0

2.4

—

Erysipelas

1.72

0.63

2.8

2.5

—

Diseases of the digestive system

1.71

0.63

1.4

2.4

—

Type 2 diabetes, wide definition

1.63

0.62

2.6

2.5

—

Arthropathies

1.62

0.62

2.3

2.7

—

Injuries to the hip and thigh

1.66

0.61

2.6

2.4

—

Episodal and paroxysmal disorders

1.64

0.61

2.5

—

Dorsalgia

1.57

0.60

2.6

2.8

—

Combinations of oral blood glucose lowering drugs

0.00

0.60

0.0

2.9

—

Other and unspecified effects of external causes

0.00

0.60

0.0

2.2

—

Lyme disease

0.00

0.60

0.0

2.6

—

Lyme disease, including avohilmo

0.00

0.60

0.0

2.7

—

Spirochaetal infections, other/unspecified, including avohilmo

0.00

0.60

0.0

2.7

—

Other spirochaetal diseases

0.00

0.60

0.0

2.7

—

Systemic connective tissue disorders

0.00

0.60

0.0

2.1

—

Other acute lower respiratory infections

1.64

0.60

2.0

2.5

—

Mycoses, including avohilmo

1.56

0.60

3.0

2.5

—

Other spirochaetal diseases, including avohilmo

0.00

0.60

0.0

2.6

—

Acute tubulo-interstitial nephritis

1.69

0.57

2.3

2.7

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1.52

0.55

2.4

2.6

—

All-cause Heart Failure

1.60

0.55

2.5

2.7

—

Heart failure, strict

1.60

0.55

2.5

2.7

—

Diabetes, insulin treatment (Kela reimbursement)

1.49

0.54

2.4

2.7

—

Persons encountering health services for specific procedures and health care

1.47

0.54

3.1

2.3

—

Coronary atherosclerosis

1.58

0.54

3.2

2.5

—

Abdominal and pelvic pain

1.46

0.53

2.0

2.2

—

Arthrosis

1.56

0.53

1.7

2.9

—

Soft tissue disorders

1.44

0.53

2.0

2.7

—

Symptoms and signs involving the skin and subcutaneous tissue

1.53

0.52

2.2

2.5

—

Acute upper respiratory infections of multiple and unspecified sites

1.59

0.50

2.7

2.4

—

Ischaemic heart disease, wide definition

1.54

0.49

2.9

2.5

—

Major coronary heart disease event

1.49

0.48

2.7

2.5

—

Neurotic, stress-related and somatoform disorders

1.46

0.47

2.9

2.5

—

Emergency coronary revascularization (for ACS)

1.46

0.47

2.7

2.6

—

Codeine

1.45

0.47

2.3

2.6

—

Insomnia

1.43

0.46

1.6

2.7

—

Sleep disorders

1.42

0.45

1.6

2.7

—

Anxiety disorders

1.41

0.45

2.9

2.5

—

Asthma, including avohilmo

1.49

0.45

2.8

2.4

—

Cardiovascular diseases (excluding rheumatic etc)

1.68

0.44

2.2

—

Constipation

1.46

0.43

1.6

2.7

—

Polyp of the female genital tract

0.00

0.43

0.0

3.6

—

Cardiac arrhythmias

1.60

0.43

3.0

2.4

—

Uterine polyps

0.00

0.43

0.0

3.6

—

Other antidepressants

1.41

0.43

3.1

2.4

—

Hypothyroidism, strict autoimmune

1.56

0.42

2.2

2.5

—

Disorders of synovium and tendon

1.57

0.42

2.8

2.5

—

Abnormal findings on examination of blood, without diagnosis

1.56

0.42

2.6

2.5

—

Other diseases of urinary system

1.36

0.41

2.4

2.6

—

Medicines for HER+ breast cancer

0.00

0.41

0.0

2.7

—

Other fall from one level to another

0.00

0.41

0.0

2.0

—

Aneurysms, operations, SAH

0.00

0.41

0.0

2.3

—

Nontraumatic intracranial haemmorrhage

0.00

0.41

0.0

1.8

—

Coagulation defects, purpura and other haemorrhagic conditions

0.00

0.41

0.0

1.8

—

Other and unspecified polyneuropathies, also in other diseases

0.00

0.41

0.0

2.5

—

Acute pancreatitis (for exclusion)

0.00

0.41

0.0

2.4

—

Other diseases of blood and blood-forming organs, wide

0.00

0.41

0.0

2.3

—

Other extrapyramidal and movement disorders in other diseases

0.00

0.41

0.0

2.4

—

Other bacterial intestinal infections, including avohilmo

0.00

0.41

0.0

2.9

—

Migraine with aura

0.00

0.41

0.0

2.5

—

Other noninfective gastroenteritis and colitis

0.00

0.41

0.0

2.3

—

Speech therapy

0.00

0.40

0.0

2.4

—

Obesity, other/unspecified

0.00

0.40

0.0

3.0

—

Open wound of head

1.47

0.40

2.2

2.3

—

Herpesviral [herpes simplex] infections, including avohilmo

0.00

0.40

0.0

2.7

—

Other systemic involvement of connective tissue

0.00

0.40

0.0

2.1

—

Heart failure,strict

1.45

0.40

2.8

2.7

—

Injuries to the head

1.40

0.39

1.9

2.6

—

Infections of the skin and subcutaneous tissue

1.45

0.39

3.4

2.2

—

Angina pectoris

1.44

0.39

2.8

2.6

—

Other diseases of hard tissues of teeth

1.44

0.39

3.6

2.3

—

Acute upper respiratory infections

1.38

0.39

2.9

2.5

—

Alcohol use disorder, Swedish definition

1.42

0.39

2.4

2.5

—

Exclusions for E4_PCOS_CONSORTIUM

1.42

0.39

2.6

2.5

—

Varicose veins

1.40

0.38

2.4

—

Missing teeth due to accident, extraction or parodontitis

1.39

0.38

3.8

2.6

—

Obesity

1.38

0.38

2.0

2.5

—

Obesity and other hyperalimentation

1.38

0.38

2.0

2.5

—

Benign neoplasm of colon, rectum, anus and anal canal

1.36

0.37

1.6

2.8

—

Pain in throat and chest

1.48

0.37

2.5

2.6

—

Hypertension, essential

1.47

0.37

2.0

2.3

—

Hypertensive diseases

1.47

0.37

2.0

2.3

—

Hypertension

1.47

0.36

2.0

2.3

—

Behavioural syndromes associated with physiological disturbances and physical factors

1.39

0.32

1.6

2.7

—

Caries of enamel

1.39

0.32

4.6

2.2

—

Hernia

1.37

0.32

2.1

2.9

—

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

1.35

0.31

2.3

2.7

—

Sleep apnoea

1.30

0.30

2.0

2.6

—

Disorders of the thyroid gland

1.30

0.30

2.0

2.5

—

Injuries to the wrist and hand

1.32

0.29

2.4

2.6

—

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

1.28

0.28

2.4

2.6

—

Diabetes medication

1.26

0.28

1.8

2.5

—

Nerve, nerve root and plexus disorders

1.26

0.28

2.0

2.7

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1.25

0.28

2.3

2.4

—

Diseases of the musculoskeletal system and connective tissue

1.39

0.24

2.2

2.8

—

Depression or dysthymia

1.36

0.24

2.0

2.6

—

1.35

0.23

2.4

2.6

—

Other nutritional deficiencies

1.34

0.23

2.0

2.5

—

1.32

0.23

2.4

2.6

—

Dermatitis

1.32

0.23

1.6

2.3

—

Statin medication

1.28

0.23

3.4

2.1

—

Chronic diseases of tonsils and adenoids

1.26

0.23

4.0

2.5

—

Diarrhoea and gastroenteritis of presumed infectious origin

1.27

0.23

2.4

2.7

—

Injuries to the ankle and foot

1.26

0.22

2.0

2.4

—

Postmenopausal atrophic vaginitis

0.00

0.22

0.0

3.5

—

Rotator cuff syndrome

1.23

0.22

2.0

2.8

—

Other disorders of urethra and urinary system

1.20

0.21

2.6

2.7

—

Other intervertebral disc disorders

1.19

0.21

2.6

3.0

—

Disorders of psychological development

0.00

0.21

0.0

1.5

—

Dysplasia of cervi uteri

0.00

0.21

0.0

3.6

—

Disturbance of activity and attention

0.00

0.21

0.0

1.7

—

Use of rivastigmine

0.00

0.21

0.0

1.6

—

Abscess of anal and rectal regions

0.00

0.21

0.0

2.3

—

Graves disease, strict definition

0.00

0.21

0.0

1.7

—

Disorders of continuity of bone

0.00

0.21

0.0

1.6

—

Agranulocytosis

0.00

0.21

0.0

1.8

—

Thiazolidinediones

0.00

0.21

0.0

1.9

—

Purpura and other haemorrhagic conditions

0.00

0.21

0.0

1.6

—

Disorders of muscles

0.00

0.21

0.0

2.2

—

Abnormal spermatozoa

0.00

0.21

0.0

2.0

—

Other disorders of bladder

0.00

0.21

0.0

1.6

—

Thyroiditis, ILD-related definition

0.00

0.21

0.0

2.1

—

Other keratitis

0.00

0.21

0.0

2.4

—

Pruritus

0.00

0.21

0.0

2.0

—

Herpesviral [herpes simplex] infections

0.00

0.21

0.0

1.6

—

Superficial injury of shoulder and upper arm

0.00

0.21

0.0

2.1

—

Use of levodopa decarboxylase inhibitor

0.00

0.21

0.0

1.9

—

Parkinson's disease, strict definition

0.00

0.21

0.0

1.9

—

Noninfectious colitis NAS

0.00

0.21

0.0

1.6

—

Parkinson's disease

0.00

0.21

0.0

1.9

—

Lateral epicondylitis

0.00

0.21

0.0

2.4

—

Restless leg syndrome

0.00

0.21

0.0

2.0

—

Other disorders of the musculoskeletal system and connective tissue

0.00

0.21

0.0

1.8

—

Valvular operations

0.00

0.21

0.0

2.4

—

Thyrotoxicosis with diffuse goitre

0.00

0.21

0.0

2.1

—

Malignant melanoma

0.00

0.21

0.0

2.2

—

Alcohol abuse, main dg

0.00

0.21

0.0

2.2

—

Atrophic disorders of skin

0.00

0.21

0.0

2.4

—

D07AA Corticosteroids, weak (group I)

0.00

0.21

0.0

1.5

—

Radiculopathy

0.00

0.21

0.0

2.9

—

Malignant melanoma, including Hilmo

0.00

0.21

0.0

2.2

—

Other bacterial intestinal infections

0.00

0.21

0.0

1.8

—

Spondylolisthesis/Spondylolysis

0.00

0.21

0.0

2.9

—

HSIL lesion of the cervix uteri, vagina or vulva

0.00

0.21

0.0

2.4

—

Other and unspecified nerve root and plexus disorders, also in other diseases

0.00

0.21

0.0

2.4

—

Cervicalgia

0.00

0.21

0.0

2.7

—

Complications predominantly related to the puerperium

0.00

0.21

0.0

2.9

—

All dysplastic lesions of the cervix uteri

0.00

0.21

0.0

2.4

—

Hyperkinetic disorders

0.00

0.21

0.0

1.6

—

Dizziness and giddiness

1.18

0.21

1.8

2.5

—

Other menopausal disorders

0.00

0.21

0.0

3.5

—

Other bursopathies

0.00

0.21

0.0

2.3

—

Myopia

0.00

0.21

0.0

1.5

—

Injury of muscle and tendon at lower leg level

0.00

0.21

0.0

2.2

—

Schizophrenia

0.00

0.21

0.0

2.2

—

Parkinson's disease, including avohilmo

0.00

0.21

0.0

2.0

—

Superficial injury of abdomen, lower back and pelvis

0.00

0.21

0.0

2.2

—

Migraine with aura and triptan purchases

0.00

0.21

0.0

2.2

—

Cholecystitis

0.00

0.21

0.0

1.8

—

DVT of lower extremities

0.00

0.21

0.0

2.3

—

Fracture of skull and facial bones

0.00

0.21

0.0

2.3

—

Enthesopathies of lower limb, excluding foot

0.00

0.21

0.0

2.6

—

Generalized anxiety disorder

0.00

0.21

0.0

2.2

—

L02BG Aromatase inhibitors

0.00

0.21

0.0

2.6

—

Allergic contact dermatitis

0.00

0.21

0.0

1.8

—

Superficial injury of thorax

0.00

0.21

0.0

2.1

—

Other diseases of liver

0.00

0.21

0.0

1.8

—

Persistent mood disorders

0.00

0.21

0.0

2.3

—

Acute pancreatitis

0.00

0.21

0.0

2.3

—

Myocardial infarction, with ST-elevation

0.00

0.21

0.0

1.8

—

Hard cardiovascular diseases

1.27

0.21

1.8

2.4

—

Shoulder lesions

1.24

0.20

1.8

2.8

—

Bipolar affective disorders

0.00

0.20

0.0

2.3

—

Other and unspecified urticaria

0.00

0.20

0.0

2.1

—

Adverse effects, not elsewhere classified

0.00

0.20

0.0

1.8

—

Pain (limb, back, neck, head abdominally)

1.20

0.20

2.0

2.6

—

Other systemic involvement of connective tissue (FG)

0.00

0.20

0.0

2.8

—

Other diseases of intestines

1.18

0.18

2.7

2.5

—

Other (not insulin) diabetes medications

1.17

0.18

2.4

2.6

—

Conjunctivitis (acute, non atopic), including avohilmo

1.17

0.18

2.0

2.7

—

Biguanides

1.17

0.18

2.4

2.6

—

Codeine or tramadol medication

1.14

0.16

2.1

2.5

—

Intestinal infectious diseases, including avohilmo, including avohilmo

1.11

0.16

1.9

2.6

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

1.12

0.10

2.2

2.5

—

Disorders of conjunctiva

1.11

0.10

2.8

2.5

—

Other heart diseases, wide

1.13

0.09

3.0

2.3

—

Dental pulpitis, including avohilmo

1.13

0.09

1.7

2.6

—

Artrosis, including avohilmo

1.06

0.09

1.7

2.9

—

Type 2 diabetes

0.83

0.08

1.6

2.6

—

Diabetes, varying definitions

0.78

0.08

1.6

2.5

—

Diabetes mellitus

0.78

0.08

1.6

2.5

—

Gingivitis and periodontal diseases

1.06

0.08

2.4

—

Fall on same level

0.84

0.08

2.3

2.5

—

Other congenital malformations of the digestive system

0.00

0.0

1.8

—

Enterocolitis due to Clostridium difficile

0.00

0.0

1.8

—

Certain zoonotic bacterial diseases, including avohilmo

0.00

0.0

1.7

—

Viral encephalitis, not elsewhere classified/unspecified, including avohilmo

0.00

0.0

1.7

—

Collagenous colitis

0.00

0.0

1.7

—

Benign neoplasm: Pancreas

0.00

0.0

1.6

—

Haemolytic anaemias

0.00

0.0

1.8

—

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

0.00

0.0

1.6

—

Disorder of external ear, unspecified

0.00

0.0

1.2

—

Pathological resorption of teeth

0.00

0.0

1.8

—

Universal erythroderma, KELA reimbursement

0.00

0.0

1.6

—

Dermatitis due to substances taken internally

0.00

0.0

2.0

—

Cervical polyps

0.00

0.0

4.0

—

Other noninflammatory disorders of vulva and perineum

0.00

0.0

3.6

—

Metatarsalgia

0.00

0.0

1.7

—

Olecranon bursitis

0.00

0.0

2.1

—

Other/unspecified soft tissue disorders related to use, overuse and pressure

0.00

0.0

1.2

—

Disorders of synovium and tendon in diseases classified elsewhere

0.00

0.0

1.2

—

Polypectomy (DHB20)

0.00

0.0

1.8

—

Puerperal sepsis

0.00

0.0

2.0

—

L02BA Anti-estrogens

0.00

0.0

2.7

—

L01XX Other antineoplastic agents

0.00

0.0

1.2

—

Burn and corrosion of hip and lower limb, except ankle and foot

0.00

0.0

1.8

—

L01XE Protein kinase inhibitors

0.00

0.0

1.2

—

Sequelae of injuries of lower limb

0.00

0.0

1.5

—

Other symptoms and signs involving the circulatory and respiratory systems

0.00

0.0

1.4

—

Dislocation, sprain and strain of joints and ligaments of elbow

0.00

0.0

1.6

—

Injuries to the knee and lower leg

0.95

0.00

2.3

2.5

—

Injury of other and unspecified intrathoracic organs

0.00

0.0

1.9

—

Diabetic maculopathy, excluding more controls

0.00

0.0

1.7

—

Open wound of hip and thigh

0.00

0.0

1.7

—

Other and unspecified injuries of lower leg

0.00

0.0

1.7

—

Open wound of ankle and foot

0.00

0.0

1.4

—

Motorcycle rider injured in other and unspecified transport accidents

0.00

0.0

1.8

—

Overexertion and strenuous or repetitive movements

0.00

0.0

1.5

—

Pedestrian injured in collision with pedal cycle

0.00

0.0

1.7

—

Antenatal screening

0.00

0.0

1.4

—

Need for other prophylactic measures

0.00

0.0

1.7

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Isoniazid [Presence] in Urine

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS